Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dallah Healthcare CoSAU:4004 +2.06%87 3-Year ROIIC % is 5.66 as of Dec. 2025, which is 51% below its 10-year median of 11.60. GuruFocus rates SAU:4004 with a GF Score™ of 87/100 and a GF Value™ of ﷼209.29 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 619 Healthcare Providers & Services companies, Dallah Healthcare Co ranks better than 54.12% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Dallah Healthcare Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 5.66%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Dallah Healthcare Co's 3-Year ROIIC % or its related term are showing as below:
SAU:4004's 3-Year ROIIC % is ranked better than 54.12% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.48
vs SAU:4004: 5.66
Dallah Healthcare Co (SAU:4004) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Dallah Healthcare Co 3-Year ROIIC % Related Terms
Dallah Healthcare Co 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Dallah Healthcare Co's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4004 vs HCA, THC, DVA: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Dallah Healthcare Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dallah Healthcare Co 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Dallah Healthcare Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Dallah Healthcare Co (SAU:4004) has a 3-Year ROIIC % of 5.66 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Dallah Healthcare Co and its competitors. This is 51% below median its historical median of 11.60. According to the industry distribution chart, Dallah Healthcare Co ranks #284 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 45.9%.
Is Dallah Healthcare Co's 3-Year ROIIC % too high?
Dallah Healthcare Co's current 3-Year ROIIC % of 5.66 is 51% below median its 10-year median of 11.60. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.48. Dallah Healthcare Co's value of 5.66 is 62.6% above this industry median. Based on the distribution chart, Dallah Healthcare Co ranks #284 out of 619 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dallah Healthcare Co has a GF Score™ of 87/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dallah Healthcare Co ranks #284 out of 619 companies for 3-Year ROIIC %. This puts Dallah Healthcare Co in the upper half of its industry. The industry median 3-Year ROIIC % is 3.48. Dallah Healthcare Co's value of 5.66 is 62.6% above this benchmark. While the company's 10-year median is 11.60 vs. the industry median of 3.48, Dallah Healthcare Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.48, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dallah Healthcare Co's current 3-Year ROIIC % of 5.66 is 62.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Dallah Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dallah Healthcare Co's current 3-Year ROIIC % is 5.66, which is 51% below median its own 10-year median of 11.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼209.29, compared to a current price of ﷼104.00 — trading 50.3% below its estimated fair value. The current 3-Year ROIIC % is 5.66, which is 51% below median its 10-year median of 11.60 and 62.6% above the Healthcare Providers & Services industry median of 3.48. Dallah Healthcare Co's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current 3-Year ROIIC % is 5.66 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?
Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued.
The current stock price of ﷼104.00 is trading 50.3% below its estimated GF Value™ of ﷼209.29.
GuruFocus considers Dallah Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4004:
3-Year ROIIC %: 5.66 (51% below median its 10-year median of 11.60)
GF Value™: ﷼209.29 vs. price of ﷼104.00 (50.3% below fair value)
Industry Position: 62.6% above the Healthcare Providers & Services median (#284 of 619)
No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
87GF Score
Get the complete analysis for SAU:4004
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4004 has been successfully added to your 
